Pharmaceutical industry innovation and developments
| Otros Autores: | , |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Hauppauge, N.Y. :
Nova Science
c2011.
|
| Colección: | EBSCO Academic eBook Collection Complete.
Business issues, competition and entrpreneurship. |
| Acceso en línea: | Conectar con la versión electrónica |
| Ver en Universidad de Navarra: | https://innopac.unav.es/record=b31161649*spi |
Tabla de Contenidos:
- Authorized generic pharmaceuticals : effects on innovation / John R. Thomas
- Authorized generics : an interim report / FTC
- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context"
- Federal R & D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht
- Pharmaceutical R & D and the evolving market for prescription drugs / CBO
- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther
- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas
- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman
- Promotional spending for prescription drugs / CBO.
